THE ACTION OF A SPECIFIC ENZYME UPON THE DERMAL INFECTION OF RABBITS WITH TYPE III PNEUMOCOCCUS

K Goodner1, R Dubos, O T Avery

  • 1Hospital of The Rockefeller Institute for Medical Research.

Insights

An enzyme targeting Type III Pneumococcus polysaccharide capsules effectively treated dermal infections in rabbits. This enzyme demonstrated the critical role of capsular substances in pneumococcal disease progression and treatment.

Area of Science:

  • Microbiology
  • Enzymology
  • Immunology

Background:

  • Type III Pneumococcus infections pose a significant threat, often proving fatal.
  • The capsular polysaccharide is a key virulence factor in pneumococcal infections.

Purpose of the Study:

  • To evaluate the therapeutic potential of an enzyme that specifically degrades the Type III Pneumococcus capsular polysaccharide.
  • To investigate the role of the capsular substance in the pathogenesis of pneumococcal infections.

Main Methods:

  • Experimental dermal infections with Type III Pneumococcus were established in rabbits.
  • A specific enzyme targeting the capsular polysaccharide was administered in sufficient quantities.

Main Results:

  • The enzyme treatment led to a favorable and early termination of the experimental disease.
  • The enzyme's action was directly correlated with the decomposition of the capsular polysaccharide.
  • The treated infections showed a significant improvement compared to untreated, typically fatal, infections.

Conclusions:

  • The enzyme holds therapeutic promise for Type III Pneumococcus infections.
  • The study reinforces the critical importance of the capsular polysaccharide in pneumococcal pathogenesis.
  • Targeting the capsular polysaccharide with specific enzymes represents a viable therapeutic strategy.